ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $341,955 | -23.2% | 9,592 | -0.6% | 0.01% | -16.7% |
Q2 2023 | $445,062 | +47.9% | 9,648 | +91.1% | 0.01% | +20.0% |
Q2 2022 | $301,000 | -38.6% | 5,048 | -25.2% | 0.01% | 0.0% |
Q1 2022 | $490,000 | -58.5% | 6,751 | -51.9% | 0.01% | -28.6% |
Q4 2021 | $1,180,000 | -27.6% | 14,034 | -22.3% | 0.01% | -12.5% |
Q3 2021 | $1,629,000 | -6.9% | 18,060 | -1.5% | 0.01% | -11.1% |
Q2 2021 | $1,749,000 | -16.5% | 18,344 | -0.2% | 0.01% | -18.2% |
Q1 2021 | $2,094,000 | -35.0% | 18,388 | -21.0% | 0.01% | -31.2% |
Q4 2020 | $3,223,000 | +564.5% | 23,284 | +240.4% | 0.02% | +100.0% |
Q3 2016 | $485,000 | +44.8% | 6,840 | -0.0% | 0.01% | +14.3% |
Q2 2016 | $335,000 | -22.8% | 6,842 | -0.2% | 0.01% | -22.2% |
Q1 2016 | $434,000 | 0.0% | 6,855 | +61.9% | 0.01% | +50.0% |
Q2 2015 | $434,000 | -2.5% | 4,235 | -40.9% | 0.01% | 0.0% |
Q1 2015 | $445,000 | +38.6% | 7,162 | -2.2% | 0.01% | +20.0% |
Q4 2014 | $321,000 | -25.0% | 7,324 | -3.2% | 0.01% | -16.7% |
Q3 2014 | $428,000 | +25.5% | 7,567 | -0.3% | 0.01% | +20.0% |
Q2 2014 | $341,000 | -65.6% | 7,589 | -62.6% | 0.01% | -64.3% |
Q1 2014 | $992,000 | – | 20,291 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |